Current Evidence Landscape

Hand therapy research has evolved considerably since systematic investigation began in the 1990s. A 2019 systematic review identified 187 randomised controlled trials examining various hand therapy interventions, with sample sizes ranging from 20 to 240 participants.

The evidence base divides into three distinct categories. Post-surgical rehabilitation dominates the literature, with particularly robust research following flexor tendon repair, carpal tunnel release, and fracture fixation. Traumatic injury recovery represents the second major research focus, encompassing crush injuries, burns, and complex trauma. Chronic condition management forms the third category, though this area shows the most variable study quality.

Most trials examine specific interventions—exercise protocols, splinting approaches, or manual techniques—rather than comprehensive rehabilitation programmes. This fragmentation makes it challenging to determine optimal treatment combinations, though recent pragmatic trials are beginning to address real-world practice patterns.

Key Research Findings

The strongest evidence supports hand therapy following surgical procedures. A 2020 Cochrane review of post-surgical rehabilitation included 31 trials with 1,630 participants, demonstrating significant improvements in grip strength, range of motion, and functional outcomes when therapy began within 72 hours of surgery.

For flexor tendon repairs specifically, early controlled mobilisation protocols show superior results to traditional immobilisation. A landmark multicentre trial involving 164 participants found that structured exercise programmes reduced adhesion formation by 40% compared with passive approaches alone.

Chronic condition research presents a more complex picture. Arthritis management studies suggest that strengthening exercises combined with joint protection techniques reduce pain intensity by an average of 2.1 points on a 10-point scale. However, these trials typically involve small samples (30-60 participants) with significant variation in baseline severity.

Workplace injury rehabilitation shows promising but inconsistent results. Three systematic reviews published between 2018-2021 indicate that work-specific training programmes improve return-to-work rates, though the evidence quality remains moderate due to heterogeneous outcome measures.

Evidence Limitations and Gaps

Several methodological challenges limit the current evidence base. Blinding presents particular difficulties in rehabilitation research—participants and therapists cannot be masked to treatment allocation, potentially introducing performance and detection bias. Many trials also lack adequate sample sizes for detecting clinically meaningful differences.

Outcome measure inconsistency hampers meta-analysis efforts. Studies variously measure grip strength, pinch force, range of motion, pain scores, and functional assessments, making it difficult to compare interventions across trials. The absence of standardised minimal clinically important differences compounds this problem.

Long-term follow-up remains insufficient. Most trials report outcomes at 3-6 months post-treatment, yet hand injuries often require 12-18 months for complete recovery. This gap leaves questions about sustained benefit and optimal treatment duration unanswered.

Pragmatic trials examining real-world effectiveness are notably sparse. Most research occurs in specialised centres with experienced therapists, potentially limiting generalisability to routine clinical practice where expertise and resources vary considerably.

What Evidence Supports vs Remains Uncertain

The evidence clearly supports hand therapy for specific scenarios. Post-surgical rehabilitation demonstrates consistent benefit across multiple high-quality trials, particularly when treatment begins early and follows structured protocols. Traumatic injury recovery also shows reliable improvement, though optimal timing and intensity require further investigation.

Exercise-based interventions show more robust evidence than passive modalities. Strengthening programmes, range-of-motion protocols, and functional training demonstrate measurable improvements in validated outcome measures. Splinting shows benefits for specific conditions—particularly following tendon repairs and in early arthritis management.

Substantial uncertainty persists around several key areas. The optimal balance between exercise intensity and tissue protection remains unclear, particularly following complex surgeries. Treatment duration guidelines lack empirical support—most protocols derive from expert consensus rather than comparative trials.

Chronic pain management represents another evidence gap. Whilst hand therapy appears helpful for many individuals with persistent symptoms, research hasn't established which patients respond best to which approaches. The role of psychological factors in recovery also requires better investigation.

Future Research Directions

Several research priorities could strengthen the evidence base significantly. Large-scale pragmatic trials comparing comprehensive treatment programmes would better inform clinical practice than continued single-technique studies. These trials should include diverse patient populations and settings to improve external validity.

Personalised medicine approaches warrant investigation. Research exploring patient characteristics that predict treatment response could enable more targeted interventions. Genetic factors affecting tissue healing, baseline functional capacity, and psychological readiness for rehabilitation all deserve systematic study.

Technology integration presents emerging research opportunities. Digital therapeutics, virtual reality training, and sensor-guided exercise programmes show preliminary promise but require rigorous evaluation. Cost-effectiveness analyses would help healthcare systems make informed resource allocation decisions.

Longer follow-up periods are essential for understanding sustained benefit and identifying factors associated with successful long-term outcomes. Five-year follow-up studies would provide valuable insights into treatment durability and guide expectations for patients and families.